Misonix, developers of a wide range of revolutionary medical devices based on the Company’s advanced ultrasonic technology, ranging from wound care systems that remove necrotic materials and devitalized tissue to high-power surgical cutters like the BoneScalpel™ Ultrasonic Bone Cutter, reported entry into an exclusive three-year distribution agreement for the BoneScalpel with one of Thailand’s top medical device marketers, JPL Medical Co., Ltd.
Preisdent and CEO of MSON, Michael A. McManus, Jr., offered an inside peek at this latest endeavor in the Company’s campaign to dynamically grow its presence in Asian markets, hailing the relationship with JPL as a fundamental key to the overall regional strategy. McManus pointed to JPL’s rock-solid reputation for introducing high-tech all across Thailand and underscored the unique competencies of JPL as a “specialty distributor of advanced medical products.”
McManus made it very clear that the reputation JPL has established, especially in neurosurgery and spine surgery, offered an ideal vector for integration. This arrangement will allow the aggressive launcher of numerous successful high tech products, including similar devices in the medical area, to have rights throughout all of Thailand for selling the BoneScalpel. A task made all the easier by JPL’s deep network and mountains of experience in associated fields like neurosurgery, orthopedic surgery and spinal surgery.
The agreement stipulates annual minimum purchase requirements and should be a huge gateway for MSON into a broader Asian market, while providing a stable footing in Thailand that should be rapidly evident in the Company’s bottom line. As all of the preliminary training with the product has been completed and sales have already begun, the ramp-up time for market penetration is very low and receptivity should be very high based on past experiences with the medical community.
Indeed, such products are a boon to the end-user market as well, with the BoneScalpel offering osteotomy capabilities like none other. Able to make precision cuts through bone and hard tissues while preserving the essential integrity of the delicate soft tissue structures, all with the usability and ergonomics of an ultra-modern medical tool, the BoneScalpel also delivers the power of a rotary cutter without all the danger.
This is a power play for MSON, as they shrewdly maneuver for better positioning of their medical product portfolio in Asian markets from above, they are simultaneously branching out into parallel sectors like Forensics products and Ductless Fume Hoods from below and making good use of the Company’s architecture in the process.
For more information on the distribution agreement, or to keep up on the latest news and information pertaining to Misonix, Inc., please visit the Company’s website at: www.misonix.com
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment